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We report a human case of leptospirosis in which the spiro-
chete was detected by dark-field microscopy examination of
cerebrospinal fluid (CSF) and isolated from both CSF and
blood. Leptospira fainei was identified by sequencing the 16S
rDNA gene, which had been amplified by polymerase chain
reaction. This case confirms the role of L. fainei as a human
pathogen and extends its distribution to southern Europe.
eptospirosis is a worldwide zoonosis, usually transmitted
to humans through contaminated water or direct exposure
to the urine of infected animals. The clinical spectrum of the
disease ranges from an influenza-like syndrome to Weil's dis-
ease and multiple organ dysfunction syndrome (1). The caus-
ative agents of human leptospirosis belong to the genus
Leptospira, which contains both saprophytic and pathogenic
species (1). L. fainei was first isolated from pigs in Australia
(2). Subsequently, several reports based on serologic testing
suggested that L. fainei might be pathogenic for humans as
well (3,4). This potential has been recently confirmed by iso-
lating L. fainei from the urine of two patients and the blood of
one patient in Denmark (5). We report a typical case of lep-
tospirosis in which L. fainei was directly observed in the cere-
bral spinal fluid (CSF) and was isolated from both CSF and
blood.
Case Report
In February 2001, a 39-year-old man was hospitalized in
Marseilles, France, with fever and disorientation. This truck
driver lived in Portugal and had been driving in Spain for 2
weeks before entering France. He arrived in France 3 days
before admission. The day of admission, his co-workers found
him confused and febrile after sleeping in his truck. He had no
previous relevant medical history. On admission, his tempera-
ture was 40°C with tachycardia, and his blood pressure was
120/80 mm Hg. Clinical examination showed a drowsy, con-
fused man with a bilateral headache, provoked myalgia of the
legs, hepatalgia, and conjunctivitis. Neurologic examination
showed signs of meningeal irritation, including cervical rigid-
ity, Brudzinski's sign, hyperesthesia, and photophobia. There
was no rash, and the rest of the physical examination was nor-
mal. Results of biochemical investigation included increased
alanine aminotransferase (61 IU/L), aspartate aminotrans-
ferase (78 IU/L), lactate dehydrogenase (781 IU/L), fibrinogen
level (6.44 g/L), and C-reactive protein (273 mg/L), associated
with hypoglycemia (2.9 mmol/L), hypoalbuminemia (26 g/L),
hypoproteinemia (54 g/L), and hypocholesterolemia (2.3
mmol/L). The leukocyte count was 11,000/mm3 with 69%
polymorphonuclear forms. Thrombocytopenia (110 G/L) was
also observed. The kaolin cephalin time was 58 s (control 34
s), and the prothrombin rate was 42%. Blood smears showed
no parasites. Cerebral scanning was normal. Analysis of the
CSF on day 1 showed 4 leukocytes/mm3, 50,000 erythrocytes/
mm3, and elevated protein levels (1.48 g/L). On day 2, another
CSF analysis showed 75 leukocytes/mm3, with 70% polymor-
phonuclear forms, 5,500 erythrocytes/mm3, and increased pro-
tein (0.64 g/L). Direct examination by dark-field microscopy
of the CSF from day 2 was performed and controlled by two
experimental investigators, who observed many spirochetes
(6). The patient received a 10-day treatment with 12 g/day
intravenous amoxicillin. The fever decreased to 38°C on day 4
and resolved on day 7. The patient was discharged from the
hospital and remained well. No occupational or recreational
risks for leptospirosis could be established. The patient had
been traveling recently in Spain and Portugal but had no
apparent exposure to sources of leptospires. 
The Study 
Specific diagnostic tools were used to identify the spiro-
chete responsible for this infection. Single 0.1 mL- and 0.01
mL-aliquots of lithium-heparin anticoagulated whole blood
were spread onto 10 mL of Leptospira medium, a polysorbate
medium similar to Ellinghausen and McCullough modified
Johnson and Harris medium (EMJH)  (Bio-Rad Laboratories,
Inc., Aulnay/Bois, France), and was incubated at 30°C. The
same procedure was carried out for CSF. For urine samples,
the specimens were first filtered on 0.45- and then 0.22-µm fil-
ters before inoculation. Once a week, 10 µL of culture medium
was examined by dark-field microscopy. Cultures from both
blood and CSF were positive and yielded Leptospira after 1
week of incubation. Urine cultures remained negative. No
agglutination of the isolated strain was obtained with any ref-
erence sera, except a weak agglutination (titer 400) with sero-
var hurstbridge antiserum. The genomic DNA of the
spirochete was extracted from the blood culture by the Qiamp
blood kit procedure (QIAGEN GmbH, Hilden, Germany). For
polymerase chain reaction (PCR), universal 16S rDNA prim-
ers fD1 and rP2 (7) were used, and sequences of the PCR
products were obtained as previously described (8). The 16S
rDNA sequence of the isolate had 100% identity with the pro-
totype strain sequence of L. fainei (GenBank accession no.
60594) (Figure 1). Pulsed-field gel electrophoresis of NotI
macrorestriction fragments of Leptospira DNAs was per-
formed as previously described (9). However, the NotI mac-
rorestriction pattern was quite different from all patterns
previously recorded for a large collection of Leptospira strains
belonging to different species and serovars (Figure 2). Sera
collected on days 4, 8, 10, and 45 were tested by a microim-
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munofluorescent antibody assay (MIFA) with L. biflexa sero-
var patoc, L. fainei, L. interrogans, and own strain as antigens
(cut-off titer _200); Western immunoblot with L. biflexa patoc
and L. fainei as antigens; and a microagglutination test (MAT)
(10,11). For MAT, sera were incubated with suspensions of
live leptospires belonging to 17 distinct serogroups, including
a strain of L. fainei serovar hurstbridge. The titer was defined
as the highest dilution giving 50% agglutination. The presence
of immunoglobulin (Ig) M was investigated by an enzyme-
linked immunosorbent assay (ELISA) developed at the Institut
Pasteur, with serovar patoc as an antigen (12). All sera were
negative by MIFA, MAT, and IgM ELISA, even when L. fainei
was used as an antigen. For Western blot, the spirochetes were
grown on Leptospira medium centrifuged and used at a con-
centration of 2 mg/mL. After blocking, the nitrocellulose was
incubated overnight at 4°C with patient sera diluted 1:50.
Seroconversion was demonstrated by Western blot analysis.
The first two sera were negative by Western blot, but a reac-
tion with L. fainei was observed in IgG and IgM at days 10 and
45. Sera reacted with protein bands of 28, 25, 24, and 19 kDa
from L. fainei, while no reaction was obtained with serovar
patoc (Figure 3).
Conclusions
This clinical picture was highly suggestive of leptospiro-
sis, with the association of meningeal syndrome, provoked leg
myalgias, and conjunctivitis; nonspecific laboratory findings
included hepatic enzyme elevation, hyperleukocytosis, throm-
bocytopenia, and low prothrombin rate (1). In fact, the case
was considered clinically to be leptospirosis. The isolated Lep-
tospira was identified as closely related to L. fainei on the
basis of 16rRNA amplification and sequencing. The strain has
been isolated in our laboratory in Marseille, where this species
had never been cultivated. Thus, laboratory contamination is
unlikely, and the isolated strain of L. fainei, which is close to
Figure 1. Dendogram representing phylogenetic relationships among
members of the genus Leptospira. The tree was derived from a 1,295-
bp fragment of the 16S rRNA gene and was constructed by the neigh-
bor-joining method. Bootstrap values, expressed as a percentage of
1,000 replications, are given at the branching point. GenBank acces-
sion numbers are given in parentheses.
Figure 2. NotI restriction patterns of Leptospira strains obtained with the
Bio-Rad apparatus (Richmond, CA) with a pulse time ramped from 5 to
90 s for 36 h. The lanes contain lambda concatemers (lanes 1 and 10)
and DNA from isolates: patient strain (lane 2); L. fainei hurstbridge,
strain But 6 (lane 3); L. inadai Lyme, strain 10 (lane 4); L. inadai biflexa,
strain LT430 (lane 5); L. biflexa patoc, strain Patoc I (lane 6); L. meyeri
semaranga, strain VS173 (lane 7); L. kirschneri grippotyphosa, strain
MoskvaV (lane 8); and L. interrogans icterohaemorrhagiae, strain Ver-
dun (lane 9).Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 867
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the serovar hurstbridge, can be considered the causative agent
of the patient’s meningitis. Moreover, a spirochete resembling
a leptospire was seen by well-trained investigators at the dark-
field microscope. 
L. fainei has been only recently been considered an emerg-
ing pathogen. In Australia, a sample of 723 human sera from
patients from a dairy and pig-producing area of Victoria, all of
whom had symptoms consistent with leptospirosis, was sub-
mitted for leptospirosis serologic testing. The sera were also
tested for antibodies to L. fainei serovar hurstbridge. MAT
titers >128 were detected in 13.4% (3). Furthermore, a lep-
tospirosis surveillance program was conducted for 12 months
on the entire population of the Seychelles; the incidence of
leptospirosis was 10/100,000, with a 20 % seroprevalence of
L. fainei. This organism was suspected to be involved in
severe forms such as acute renal failure, pulmonary hemor-
rhage, and possibly death (4). 
The first human isolation of L. fainei occurred in Denmark,
from two patients (5). The first patient had chronic disease
with increasing jaundice for 6 months before admission to the
hospital, and test results showed elevated hepatic enzymes.
The second patient had abdominal and lower back pain for 5
months and severe headaches and dizziness for 2 months
before admission. Thus, both patients had atypical chronic dis-
ease, unlike the typical case of leptospirosis that we describe. 
In our case, we tested sera 4, 8, 10, and 45 days after onset
of illness. No reactivity was detected by MIF and MAT tests,
although a reaction in IgG and IgM at day 10 and 45 was
detected by Western blot. Early antibiotic treatment may have
affected the serologic responses. The two Danish patients from
whom L. fainei was isolated were tested by MAT and showed
no substantial serologic reaction (5). However, published sero-
logic studies have shown that an immunologic response may
be observed, in some cases at a high level (4). As reported
here, Western blot may prove to be a good tool for diagnosis.
Antibiotic treatment by amoxicillin (12 g/day for 10 days) was
effective. In the Seychelles, for 8 patients among 75 with con-
firmed leptospirosis, a 5-day treatment with penicillin was
insufficient to eradicate the bacteria, as indicated by positive
PCR results (4). Treatment for longer than 1 week may be nec-
essary, because L. fainei could be still isolated from Danish
patients after a 1-week treatment with intravenous penicillin,
but not after 4 weeks of amoxicillin treatment (3). 
This case confirms the pathogenic role of L. fainei in
humans and extends its geographic distribution to southern
Europe. The clinical finding of our case did not differ from
that of other Leptospira infections, but the route of exposure
remains unknown. Although the usual procedures of direct
detection, isolation, and identification of leptospires are effec-
tive for L. fainei, we did not observe substantial serologic reac-
tivity. Further studies, including Western blot, are needed to
explain the weak immune response and to evaluate the preva-
lence of infection by this newly discovered Leptospira species.
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